PKDL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL) (NCT01635777) | AB Foundation | 2007-07-01 |
Track PKDL automatically
Every clearance here is in the API, with alerts when new ones post.